"Dr. Mani Nallasivan and staff are dedicated to providing high quality medical and surgical care to patients with vascular disease. We are responsive to needs of referring physicians, managed care organizations and their patients, offering our services to our neighbors in Merced, Mariposa and Madera counties and the Northern Central Valley."

During the past decade, Merced Vein and Vascular Center conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 2 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Merced Vein and Vascular Center" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Merced Vein and Vascular Center" are "Heart Failure" (2 trials). Many other conditions were trialed in "Merced Vein and Vascular Center" in a lesser frequency.

Most popular intervention types in "Merced Vein and Vascular Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Empagliflozin" (2 trials) and "Placebo" (2 trials). Other intervention names were less common.

The vast majority of trials in "Merced Vein and Vascular Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Merced Vein and Vascular Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Merced Vein and Vascular Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Merced Vein and Vascular Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".